home / stock / ogn / ogn news


OGN News and Press, Organon & Co. From 05/03/23

Stock Information

Company Name: Organon & Co.
Stock Symbol: OGN
Market: NYSE
Website: organon.com

Menu

OGN OGN Quote OGN Short OGN News OGN Articles OGN Message Board
Get OGN Alerts

News, Short Squeeze, Breakout and More Instantly...

OGN - Organon Q1 2023 earnings on deck, what to expect

2023-05-03 14:25:08 ET Organon ( NYSE: OGN ) is scheduled to announce Q1 earnings results on Thursday, May 4th, before market open. The consensus EPS estimate is $1.16 and the consensus revenue estimate is $1.54B. Over the last 1 year, OGN has beaten EPS estimates ...

OGN - Organon To Report First Quarter and Host Conference Call on May 4, 2023

Organon (NYSE: OGN), a global women’s healthcare company will release its first quarter 2023 financial results on May 4, 2023, prior to the company’s webcast and conference call scheduled for 8:30 a.m. EDT. Interested parties may access the live call via webcast on the Organon w...

OGN - Lifezone Metals launches off-take marketing process for nickel, copper and cobalt from the Kabanga nickel project

Lifezone Metals launches off-take marketing process for nickel, copper and cobalt from the Kabanga nickel project PR Newswire LONDON , April 19, 2023 /PRNewswire/ -- Lifezone Holdings Limited ("Lifezone Metals") has previously announced entry into a Business Comb...

OGN - Organon: A Bitter Pill

2023-03-24 14:03:55 ET Summary Organon & Co. has seen mostly margin disappointments since the spinoff from Merck & Co., Inc. While the performance is not comforting, valuations are non-demanding. Leverage is high, but stabilization in the business, longer-term maturiti...

OGN - Organon draws bullish views at Raymond James on Humira biosimilar launch

2023-03-16 08:34:23 ET Raymond James launched its coverage on Organon ( NYSE: OGN ) with an Outperform recommendation citing its potential in the biosimilar space with the upcoming launch of Hadlima, a copycat version of AbbVie's ( ABBV ) blockbuster arthritis therapy Humira...

OGN - Biosimilars expected to save $180B over next five years as more gain approval

2023-03-12 10:00:00 ET Biosimilar medication, generic versions of typically expensive biologic-based drugs, are set to save patients and the health care system $180B over the next five years as even more hit the market. New launches and an expected increase in uptake of biosimilars ...

OGN - Organon Launches "Her Plan is Her Power," a New Global Initiative to Reduce Unplanned Pregnancies Where Need is Great and Disparities Exist

Building on Organon’s Prior FP2030 Commitment, the Company Announces $30 Million in New Funding to Fuel Global Action and Community-Driven Solutions Needed by the 121 Million Women and Girls Who Experience Unplanned Pregnancies Each Year Organon (NYSE: OGN), a global healthcare c...

OGN - Tracking Kahn Brothers Portfolio - Q4 2022 Update

2023-03-06 23:01:05 ET Summary Kahn Brothers’ 13F portfolio value increased from ~$642M to ~$760M this quarter. Most of the stakes saw minor adjustments during the quarter. The portfolio continues to be very concentrated with the top five positions accounting for ~49% o...

OGN - Organon Canada receives the Women in Governance (WiG) Parity Certification SME, further demonstrating its commitment to gender parity in the workplace

Organon Canada receives the Women in Governance (WiG) Parity Certification SME, further demonstrating its commitment to gender parity in the workplace Canada NewsWire The WiG evaluation, which comprises over 75 quantitative and qualitative criteria, showcases Organon Canada's ...

OGN - Moneghetti Minerals Limited Identifies New Drill Targets at the Ecru Gold Project, Nevada

Sydney, Australia (ABN Newswire) - Moneghetti Minerals Limited (Moneghetti, the Company) today announced it has identified new high-priority drill targets at the Company's flagship Ecru Gold Project (Ecru) located in the well endowed Cortez District, Nevada USA. The Ecru Project is a Carlin-t...

Previous 10 Next 10